Quality not quantity: The role of marine natural products in drug discovery and reverse chemical proteomics

Marine Drugs

Volumn 3, Issue 2, 2005, Pages 36-63

  Piggott, Andrew M ^a   Karuso, Peter ^a  

^a MACQUARIE UNIVERSITY   (Australia)

Author keywords

Palau'amine; Phage display; Reverse chemical proteomics

Indexed keywords

AMINE; ANTINEOPLASTIC AGENT; EPONEMYCIN; EPOXOMICIN; FUMAGILLIN; FUMAGILLOL CHLOROACETYLCARBAMATE; ILIMAQUINONE; NATURAL PRODUCT; POLYSTYRENE; RECEPTOR; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; BIOLOGICAL ACTIVITY; CHEMICAL PROCEDURES; DERIVATIZATION; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG RESEARCH; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC LINKAGE; ISOLATION PROCEDURE; MICROTITER PLATE ASSAY; MOLECULAR PROBE; MOLECULAR SIZE; PHAGE DISPLAY; PROTEIN ANALYSIS; PROTEIN ISOLATION; PROTEOMICS; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RECEPTOR AFFINITY; REVIEW; SEQUENCE ANALYSIS; TECHNIQUE; TECHNOLOGY;

EID: 23044453692     PISSN: 16603397     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md302036     Document Type: Review

References (71)

1. Rouhi, A. M. Rediscovering Natural Products. Chem. Eng. News 2003, 81, 77-91.
2. Newman, D. J.; Cragg, G. M.; Snader, K. M. Natural products as sources of new drugs over the period 1981-2002. J. Nat. Prod. 2003, 66, 1022-1037.
3. Feher, M.; Schmidt, J. M. Property distributions: Differences between drugs, Natural Products, and molecules from combinatorial chemistry. J. Chem. Inf. Comput. Sci. 2003, 43, 218-227.
4. Adam, G. C.; Sorensen, E. J.; Cravatt, B. F. Proteomic profiling of mechanistically distinct enzyme classes using a common chemotype. Nat. Biotechnol. 2002, 20, 805-809.
5. Jeffery, D. A.; Bogyo, M. Chemical proteomics and its application to drug discovery. Curr. Opin. Biotechnol. 2003, 14, 87-95.
6. Patricelli, M. P.; Giang, D. K.; Stamp, L. M.; Burbaum, J. J. Direct visualization of serine hydrolase activities in complex proteomes using fluorescent active site-directed probes. Proteomics 2001, 1, 1067-1071.
7. Speers, A. E.; Cravatt, B. F. Chemical strategies for activity-based proteomics. ChemBioChem 2004, 5, 41-47.
8. Zhao, G.; Meier, T. I.; Kahl, S. D.; Gee, K. R.; Blaszczak, L. C. BOCILLIN FL, a sensitive and commercially available reagent for detection of penicillin-binding proteins. Antimicrob. Agents Chemother. 1999, 43, 1124-1128.
9. 3H. J. Cell Biol. 1965, 25, 145-160.
10. Borisy, G. G.; Taylor, E. W. The mechanism of action of colchicine. Binding of colchicine-3H to cellular protein. J. Cell Biol. 1967, 34, 525-533.
11. Borisy, G. G.; Taylor, E. W. The mechanism of action of colchicine. Colchicine binding to sea urchin eggs and the mitotic apparatus. J. Cell Biol. 1967, 34, 535-548.
12. Shelanski, M. L.; Taylor, E. W. Isolation of a protein subunit from microtubules. J. Cell Biol. 1967, 34, 549-554.
13. Weisenberg, R. C.; Broisy, G. G.; Taylor, E. W. Colchicine-binding protein of mammalian brain and its relation to microtubules. Biochemistry 1968, 7, 4466-4479.
14. Piggott, A. M.; Karuso, P. Quality, not quantity: The role of natural products and chemical proteomics in modern drug discovery. Comb. Chem. High Throughput Screen. 2004, 7, 607-630.
15. Sin, N.; Meng, L.; Wang, M. Q. W.; Wen, J. J.; Bornmann, W. G.; Crews, C. M. The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2. Proc. Nat. Acad. Sci. USA 1997, 94, 6099-6103.
16. Sin, N.; Meng, L.; Auth, H.; Crews, C. M. Eponemycin analogues: syntheses and use as probes of angiogenesis. Bioorg. Med. Chem. 1998, 6, 1209-1217.
17. Abe, J.; Zhou, W.; Takuwa, N.; Taguchi, J.; Kurokawa, K.; Kumada, M.; Takuwa, Y. A fumagillin derivative angiogenesis inhibitor, AGM-1470, inhibits activation of cyclin-dependent kinases and phosphorylation of retinoblastoma gene product but not protein tyrosyl phosphorylation or protooncogene expression in vascular endothelial cells. Cancer Res. 1994, 54, 3407-3412.
18. Lowther, W. T.; McMillen, D. A.; Orville, A. M.; Matthews, B. W. The anti-angiogenic agent fumagillin covalently modifies a conserved active-site histidine in the Escherichia coli methionine aminopeptidase. Proc. Nat. Acad. Sci. USA 1998, 95, 12153-12157.
19. Liu, S.; Widom, J.; Kemp, C. W.; Crews, C. M.; Clardy, J. Structure of human methionine aminopeptidase-2 complexed with fumagillin. Science 1998, 282, 1324-1327.
20. Luibrand, R. T.; Erdman, T. R.; Vollmer, J. J.; Scheuer, P. J.; Finer, J.; Clardy, J. Ilimaquinone, a sesquiterpenoid quinone from a marine sponge. Tetrahedron 1979, 35, 609-612.
21. Takizawa, P. A.; Yucel, J. K.; Veit, B.; Faulkner, D. J.; Deerinck, T.; Soto, G.; Ellisman, M.; Malhotra, V. Complete vesiculation of Golgi membranes and inhibition of protein transport by a novel sea sponge metabolite, ilimaquinone. Cell 1993, 73, 1079-1090.
22. Veit, B.; Yucel, J. K.; Malhotra, V. Microtubule independent vesiculation of Golgi membranes and the reassembly of vesicles into Golgi stacks. J. Cell Biol. 1993, 122, 1197-1206.
23. Radeke, H. S.; Snapper, M. L. Photoaffinity study of the cellular interactions of ilimaquinone. Bioorg. Med. Chem. 1998, 6, 1227-1232.
24. Radeke, H. S.; Digits, C. A.; Casaubon, R. L.; Snapper, M. L. Interactions of (-)-ilimaquinone with methylation enzymes: implications for vesicular-mediated secretion. Chem. Biol. 1999, 6, 639-647.
25. Lee, S. Y.; Choi, J. H.; Xu, Z. Microbial cell-surface display. Trends Biotech. 2003, 21, 45-52.
26. Kondo, A.; Ueda, M. Yeast cell-surface display - applications of molecular display. Appl. Microbiol. Biotechnol. 2004, 64, 28-40.
27. Crews, C. M.; Collins, J. L.; Lane, W. S.; Snapper, M. L.; Schreiber, S. L. GTP-dependent binding of the antiproliferative agent didemnin to elongation factor 1α. J. Biol. Chem. 1994, 269, 15411- 15414.
28. Sche, P. P.; McKenzie, K. M.; White, J. D.; Austin, D. J. Display cloning: functional identification of natural product receptors using cDNA-phage display. Chem. Biol. 1999, 6, 707-716.
29. Sche, P. P.; McKenzie, K. M.; White, J. D.; Austin, D. J. Display cloning: Functional identification of natural product receptors using cDNA-phage display. [Erratum to document cited in CA132:45554]. Chem. Biol. 2001, 8, 399-400.
30. McKenzie, K. M.; Videlock, E. J.; Splittgerber, U.; Austin, D. J. Simultaneous identification of multiple protein targets by using complementary-DNA phage display and a Natural-Product-mimetic probe. Angew. Chem. Int. Ed. 2004, 43, 4052-4055.
31. Siekierka, J. J.; Hung, S. H. Y.; Poe, M.; Lin, C. S.; Sigal, N. H. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. Nature 1989, 341, 755-757.
32. Harding, M. W.; Galat, A.; Uehling, D. E.; Schreiber, S. L. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature 1989, 341, 758-760.
33. Videlock, E. J.; Chung, V. K.; Mohan, M. A.; Strok, T. M.; Austin, D. J. Two-dimensional diversity: Screening human cDNA phage display libraries with a random diversity probe for the display cloning of phosphotyrosine binding domains. J. Am. Chem. Soc. 2004, 126, 3730-3731.
34. Videlock, E. J.; Chung, V. K.; Hall, J. M.; Hines, J.; Agapakis, C. M.; Austin, D. J. Identification of a molecular recognition role for the activation loop phosphotyrosine of the Src tyrosine kinase. J. Am. Chem. Soc. 2005, 127.
35. 2+/calmodulin function. Chem. Biol. 2004, 11, 1455-1463.
36. Merrifield, R. B. Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. J. Am. Chem. Soc. 1963, 85, 2149-2154.
37. Delgado, M.; Janda, K. D. Polymeric supports for solid phase organic synthesis. Curr. Org. Chem. 2002, 6, 1031-1043.
38. Blaney, P.; Grigg, R.; Sridharan, V. Traceless solid-phase organic synthesis. Chem. Rev. 2002, 102, 2607-2624.
39. Guillier, F.; Orain, D.; Bradley, M. Linkers and cleavage strategies in solid phase organic synthesis and combinatorial chemistry. Chem. Rev. 2000, 100, 2091-2157.
40. James, I. W. Linkers for solid phase organic synthesis. Tetrahedron 1999, 55, 4855-4946.
41. Bochet, C. G. Photolabile protecting groups and linkers. J. Chem. Soc. Perkin Trans. 1 2002, 2, 125-142.
42. Plunkett, M. J.; Ellman, J. A. A Silicon-Based Linker for Traceless Solid-Phase Synthesis. J. Org. Chem. 1995, 60, 6006-6007.
43. Patek, M.; Lebl, M. Safety-catch and multiply cleavable linkers in solid-phase synthesis. Biopolymers 1998, 47, 353-363.
44. Rotmans, J. P.; Delwel, H. R. Cross-linking of Schistosoma mansoni antigens and their covalent binding on the surface of polystyrene microtitration trays for use in the ELISA. J. Immunol. Methods 1983, 57, 87-98.
45. Aleixo, J. A. G.; Swaminathan, B.; Minnich, S. A.; Wallshein, V. A. Enzyme immunoassay: binding of Salmonella antigens to activated microtiter plates. J. Immunoass. 1985, 6, 391-407.
46. Zammatteo, N.; Girardeaux, C.; Delforge, D.; Pireaux, J-J.; Remacle, J. Amination of polystyrene microwells: application to the covalent grafting of DNA probes for hybridization assays. Anal. Biochem. 1996, 236, 85-94.
47. Clark, B. R., Derivatized polystyrene and other polymer supports for spectroscopic studies. Aventis Pharmaceuticals Holdings Inc.: USA, 2003; p 7.
48. Bora, U.; Chugh, L.; Nahar, P. Covalent immobilization of proteins onto photoactivated polystyrene microtiter plates for enzyme-linked immunosorbent assay procedures. J. Immunol. Methods 2002, 268, 171-177.
49. Nahar, P.; Wali, N. M.; Gandhi, R. P. Light-induced activation of an inert surface for covalent immobilization of a protein ligand. Anal. Biochem. 2001, 294, 148-153.
50. Fleet, G. W. J.; Porter, R. R.; Knowles, J. R. Affinity labeling of antibodies with aryl nitrene as reactive group. Nature 1969, 224, 511-512.
51. Ito, Y.; Chen, G.; Imanishi, Y. Photoimmobilization of insulin onto polystyrene dishes for protein-free cell culture. Biotechnol. Prog. 1996, 12, 700-702.
52. Eckert, A. W.; Gröbe, D.; Rothe, U. Surface-modification of polystyrene-microtitre plates via grafting of glycidylmethacrylate and coating of poly-glycidylmethacrylate. Biomaterials 2000, 21, 441-447.
53. Larsson, P. H.; Eklund, A.; Johansson, S. G. O.; Larsson, K. Covalent binding of proteins to grafted plastic surfaces suitable for immunoassays. II. Picograms of IgE detected in BAL fluid in sarcoidosis. J. Immunol. Methods 1997, 210, 41-49.
54. Larsson, P. H.; Johansson, S. G. O.; Hult, A.; Göthe, S. Covalent binding of proteins to grafted plastic surfaces suitable for immunoassays. J. Immunol. Methods 1987, 98, 129-135.
55. Butler, J. E. Solid supports in enzyme-linked immunosorbent assay and other solid-phase immunoassays. Methods Mol. Med. 2004, 94, 333-372.
56. Kinnel, R. B.; Gehrken, H-P.; Scheuer, P. J. Palau'amine: a cytotoxic and immunosuppressive hexacyclic bisguanidine antibiotic from the sponge Stylotella agminata. J. Am. Chem. Soc. 1993, 115, 3376-3377.
57. Kinnel, R. B.; Gehrken, H-P.; Swali, R.; Skoropowski, G.; Scheuer, P. J. Palau'amine and its congeners: A family of bioactive bisguanidines from the marine sponge Stylotella aurantium. J. Org. Chem. 1998, 63, 3281-3286.
58. Garrido-Hernandez, H.; Nakadai, M.; Vimolratana, M.; Li, Q.; Doundoulakis, T.; Harran, P. G. Spirocycloisomerization of tethered alkylidene glycocyamidines: Synthesis of a base template common to the palau'amine family of alkaloids. Angew. Chem. Int. Ed. 2005, 44, 765-769.
59. Katz, J. D.; Overman, L. E. Studies towards the total synthesis of palau'amine. Formation of 4,5-dihydropyrrole-2-carboxylate intermediates by alkene-enamide ring-closing metathesis. Tetrahedron 2004, 60, 9559-9568.
60. Dilley, A. S.; Romo, D. Enantioselective Strategy to the Spirocyclic Core of Palau'amine and Related Bisguanidine Marine Alkaloids. Org. Lett. 2001, 3, 1535-1538.
61. Overman, L. E.; Rogers, B. N.; Tellew, J. E.; Trenkle, W. C. Stereocontrolled synthesis of the tetracyclic core of the bisguanidine alkaloids Palau'amine and Styloguanidine. J. Am. Chem. Soc. 1997, 119, 7159-7160.
62. Meier, U. T.; Blobel, G. A nuclear localization signal binding protein in the nucleolus. J. Cell Biol. 1990, 111, 2235-2245.
63. Jin, Y.; Yu, J.; Yu, Y. G. Identifcation of hNopp140 as a binding partner for doxorubicin with phage display cloning method. Chem. Biol. 2002, 9, 157-162.
64. +. Neurosci. Res. 2002, 44, 255-265.
65. Kim, Y-K.; Jin, Y.; Vukoti, K. M.; Park, J. K.; Kim, E. E.; Lee, K-J.; Yu, Y. G. Purification and characterization of human nucleolar phosphoprotein 140 expressed in Escherichia coli. Prot. Expr. Purif. 2003, 31, 260-264.
66. Pai, C-Y.; Chen, H-K.; Sheu, H-L.; Yeh, N-H. Cell cycle-dependent alterations of a highly phosphorylated nucleolar protein p130 are associated with nucleologenesis. J. Cell Sci. 1995, 108, 1911-1920.
67. Pai, C-Y.; Yeh, N-H. Cell proliferation-dependent expression of two isoforms of the nucleolar phosphoprotein p130. Biochem. Biophys. Res. Commun. 1996, 221, 581-587.
68. 2+. Biochem. Biophys. Res. Commun. 1997, 230, 370-375.
69. Meier, U. T.; Blobel, G. Nopp140 shuttles on tracks between nucleolus and cytoplasm. Cell 1992, 70, 127-138.
70. Savinov, S. N.; Austin, D. J. The cloning of human genes using cDNA phage display and small-molecule chemical probes. Comb. Chem. High Throughput Screen. 2001, 4, 593-597.
71. Novagen, T7Select System Manual. USA, 2000; pp 1-21.